This is the authors' abstract. We don't add key points for this paper.
A new bioprinting method is reported for fabricating 3D tissue constructs replete with vasculature, multiple types of cells, and extracellular matrix. These intricate, heterogeneous structures are created by precisely co-printing multiple materials, known as bioinks, in three dimensions. These 3D micro-engineered environments open new -avenues for drug screening and fundamental studies of wound healing, angiogenesis, and stem-cell niches.
Answers are grounded in this paper and cite their sources.
No takes yet. Share an insight, caveat, or question.
Kolesky et al. (2014) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: